Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Obstructive Lung Diseases

  Free Subscription


Articles published in Thorax

Retrieve available abstracts of 96 articles:
HTML format



Single Articles


    February 2026
  1. DOLL R
    Republished: Helium in the Treatment of Asthma.
    Thorax. 2026;81:229-237.
    PubMed    


  2. LU X, Pei Y, Geng Y, Fan Y, et al
    Adherence to the EAT-Lancet diet, plasma proteomics and the risk of chronic obstructive pulmonary disease.
    Thorax. 2026;81:282-291.
    PubMed     Abstract available


  3. YIN Y, Mehareen J, Sadatsafavi M, Brigham E, et al
    Factors associated with guideline-concordant maintenance inhaled medication for COPD: a population-based, longitudinal cohort study.
    Thorax. 2026;81:246-256.
    PubMed     Abstract available


  4. POLLOCK J, Huang JTJ, Shuttleworth M, Long MB, et al
    Clinical, molecular and microbial characterisation of the eosinophilic endotype of bronchiectasis: data from the EMBARC-BRIDGE study.
    Thorax. 2026 Feb 13:thorax-2025-223305. doi: 10.1136/thorax-2025-223305.
    PubMed     Abstract available


  5. ARBIV OA, Thornton CS
    Granules of truth: unpacking the eosinophilic endotype in bronchiectasis.
    Thorax. 2026 Feb 13:thorax-2025-224609. doi: 10.1136/thorax-2025-224609.
    PubMed    


    January 2026
  6. TAYLOR SL, Brooks CR, Pembrey L, Manning SK, et al
    Airway microbiota in young people across four continents differ by country, asthma status and inflammatory phenotype.
    Thorax. 2026 Jan 30:thorax-2025-222965. doi: 10.1136/thorax-2025-222965.
    PubMed     Abstract available


  7. PROCHASKA J, Rubinstein M, Perdok R, Blumenstein B, et al
    Cytisinicline for smoking cessation in individuals with self-reported COPD: a post hoc analysis of the ORCA-2 and ORCA-3 trials.
    Thorax. 2026;81:164-169.
    PubMed     Abstract available


  8. LIU J, Perret JL, Lodge CJ, Vicendese D, et al
    Paternal prepubertal passive smoke exposure is related to impaired lung function trajectories from childhood to middle age in their offspring.
    Thorax. 2026;81:131-139.
    PubMed     Abstract available


  9. BONNERT M, Nash S, Andersson EM, Bergstrom SEE, et al
    Online cognitive behaviour therapy for asthma-related anxiety: a randomised controlled trial.
    Thorax. 2026 Jan 6:thorax-2025-223886. doi: 10.1136/thorax-2025-223886.
    PubMed     Abstract available


    December 2025
  10. ALWADANI F, Ellis PR, Newnham M, de Soyza J, et al
    Pulmonary rehabilitation and quality of life in alpha-1 antitrypsin deficiency: findings from a retrospective cohort study.
    Thorax. 2025;81:78-80.
    PubMed     Abstract available


  11. YII A, Tay TR, Lee KCH, Chew SY, et al
    Blood eosinophil-guided systemic corticosteroid duration in adults hospitalised for asthma exacerbation: a randomised, controlled, open-label, non-inferiority trial.
    Thorax. 2025 Dec 3:thorax-2025-223961. doi: 10.1136/thorax-2025-223961.
    PubMed     Abstract available


    November 2025
  12. VERSTRAETE K, Gyselinck I, Huts H, Djamin RS, et al
    Identifying azithromycin responders with an individual treatment effect model in COPD.
    Thorax. 2025;80:900-908.
    PubMed     Abstract available


  13. SMITH LJ, Marshall H, Jakymelen D, Biancardi A, et al
    (129)Xe-MRI ventilation and acinar abnormalities highlight the significance of spirometric dysanapsis: findings from the NOVELTY ADPro UK substudy.
    Thorax. 2025;80:909-917.
    PubMed     Abstract available


  14. ATUG E, Trudzinski FC, Holland A, Grah C, et al
    Sex differences in outcome after endoscopic lung volume reduction (ELVR) in patients with emphysema: a retrospective analysis of the German Lung Emphysema Registry (LER e.V.).
    Thorax. 2025 Nov 13:thorax-2025-223559. doi: 10.1136/thorax-2025-223559.
    PubMed     Abstract available


  15. MARTINS COSTA GOMES G, Collison AM, Karmaus WJJ, Da Silva Sena CR, et al
    Association between maternal asthma and impaired infant lung function is diminished by inhaled corticosteroid use in pregnancy.
    Thorax. 2025 Nov 9:thorax-2025-223539. doi: 10.1136/thorax-2025-223539.
    PubMed     Abstract available


    October 2025
  16. LUNDHOLM C, Caffrey Osvald E, Rhedin S, Almqvist C, et al
    Maternal BMI and smoking partly explain the association between maternal socio-economic position and offspring asthma.
    Thorax. 2025 Oct 28:thorax-2025-223330. doi: 10.1136/thorax-2025-223330.
    PubMed     Abstract available


  17. XIA Y
    Why asthma progresses to COPD: environmental and genetic drivers.
    Thorax. 2025 Oct 21:thorax-2025-224038. doi: 10.1136/thorax-2025-224038.
    PubMed    


  18. LANGLEY R, Corr M, Foster S, Weir E, et al
    New NICE asthma guideline: evidence-based gold standard approach or unachievable utopia?
    Thorax. 2025 Oct 20:thorax-2025-223970. doi: 10.1136/thorax-2025-223970.
    PubMed    


  19. KOFOD LM, Hansen EF, Brocki BC, Kristensen MT, et al
    Optimised oxygenation improves functional capacity during daily activities in patients with COPD on long-term oxygen therapy: a randomised crossover trial.
    Thorax. 2025;80:803-809.
    PubMed     Abstract available


  20. SHIROSHITA A
    Clarifying the distinct risk factors of atopy and asthma in childhood.
    Thorax. 2025 Oct 8:thorax-2025-223533. doi: 10.1136/thorax-2025-223533.
    PubMed    


  21. LIVIERO F
    Occupational asthma: still an underestimated burden?
    Thorax. 2025 Oct 5:thorax-2025-223499. doi: 10.1136/thorax-2025-223499.
    PubMed    


  22. KAMINSKY DA
    Home monitoring of asthma using oscillometry: seeking the signal in the noise.
    Thorax. 2025 Oct 5:thorax-2025-223595. doi: 10.1136/thorax-2025-223595.
    PubMed    


    September 2025
  23. ZHANG X, Hartman TJ, Adgent M, Moore P, et al
    Maternal prenatal carotenoids and child lung function: exploration of modifying factors.
    Thorax. 2025;80:748-755.
    PubMed     Abstract available


  24. ZHANG W, Chen B, Shima M, Zhao C, et al
    PM(2.5) as a risk factor for sleep oxygen desaturation in COPD: identifying susceptible individuals by smoking and inflammatory phenotypes.
    Thorax. 2025;80:683-692.
    PubMed     Abstract available


  25. SYKES DL, Clarkson MD, Negbenebor A, Cummings H, et al
    Impact of regional asthma guidelines on SABA prescribing patterns across England: an interrupted time series analysis.
    Thorax. 2025 Sep 2:thorax-2025-223239. doi: 10.1136/thorax-2025-223239.
    PubMed     Abstract available


    August 2025
  26. KIMURA Y, Jo T, Inoue N, Suzukawa M, et al
    Gabapentinoids and risk for asthma exacerbations: a nationwide retrospective cohort study.
    Thorax. 2025 Aug 24:thorax-2025-223240. doi: 10.1136/thorax-2025-223240.
    PubMed     Abstract available


  27. POTTINGER T, Liu Z, Liu L, Buschur KL, et al
    Serum IgA isotypes are associated with percent emphysema, wall thickness and lung function decline.
    Thorax. 2025 Aug 22:thorax-2025-222990. doi: 10.1136/thorax-2025-222990.
    PubMed     Abstract available


  28. PEPIN JL, Herquelot E, Denis H, Josseran A, et al
    Impact of long-term non-invasive ventilation on severe exacerbations and survival in COPD: a French nationwide cohort study using multistate models.
    Thorax. 2025;80:616-623.
    PubMed     Abstract available


  29. MATHIOUDAKIS AG, Higham A, Bate S, Chatzimavridou-Grigoriadou V, et al
    Reduced treatment response to inhaled corticosteroids in current smokers with COPD, regardless of blood eosinophil count: insights from the FLAME trial.
    Thorax. 2025;80:658-661.
    PubMed     Abstract available


  30. ALARCON-MARTINEZ T, Mainzer RM, Ranganathan S, Doyle LW, et al
    Spirometry phenotypes at 8 years in children born extremely preterm or with extremely low birth weight.
    Thorax. 2025 Aug 11:thorax-2024-222602. doi: 10.1136/thorax-2024-222602.
    PubMed     Abstract available


    July 2025
  31. LI G, Zhang K, Yang T, Jin J, et al
    Air pollution, genetic susceptibility and risk of progression from asthma to COPD.
    Thorax. 2025 Jul 21:thorax-2024-222871. doi: 10.1136/thorax-2024-222871.
    PubMed     Abstract available


  32. KEMP PR, Griffiths M, Polkey MI, Sathyapala A, et al
    Variability in sensitivity to inflammation in muscle and lung of patients with COPD may underlie susceptibility to lung function decline.
    Thorax. 2025;80:520-529.
    PubMed     Abstract available


  33. COLAK Y, Nordestgaard BG, Lange P, Afzal S, et al
    Sex differences in COPD in relation to smoking exposure: a population-based cohort study.
    Thorax. 2025;80:512-519.
    PubMed     Abstract available


    June 2025
  34. RUTTER CE, Mpairwe H, Figueiredo CA, Njoroge M, et al
    Risk factors for atopic and non-atopic asthma in school-age children from high-income and low- and middle-income countries.
    Thorax. 2025 Jun 24:thorax-2024-222118. doi: 10.1136/thorax-2024-222118.
    PubMed     Abstract available


  35. HOANG MT, Wong A, Hardaker K, Peiris S, et al
    Day-to-day variability indices improve utility of oscillometry in paediatric asthma.
    Thorax. 2025 Jun 24:thorax-2024-222744. doi: 10.1136/thorax-2024-222744.
    PubMed     Abstract available


  36. JIANG M, Zhang Y, Liu T, Hong X, et al
    Circulating miRNAs and childhood asthma ICS response: a stratified analysis in the intervention arm of an RCT with vitamin D effect modification.
    Thorax. 2025 Jun 4:thorax-2024-222618. doi: 10.1136/thorax-2024-222618.
    PubMed     Abstract available


    May 2025
  37. USMANI O, Verbanck S
    Structure-function-treatment relationships of aerosol deposition in patients with severe asthma.
    Thorax. 2025 May 22:thorax-2025-223228. doi: 10.1136/thorax-2025-223228.
    PubMed    


  38. KHOR YH, Palm A, Wong AW, Guler SA, et al
    Effects of long-term oxygen therapy on acute exacerbation and hospital burden: the national DISCOVERY study.
    Thorax. 2025;80:378-384.
    PubMed     Abstract available


  39. KNOX-BROWN B, Kon FC, Sylvester KP, Jha A, et al
    Effect of time of day and seasonal variation on bronchodilator responsiveness: the SPIRO-TIMETRY study.
    Thorax. 2025;80:395-397.
    PubMed     Abstract available


    April 2025
  40. ALIF SM, Benke G, Kromhout H, Abramson MJ, et al
    Occupational exposures and incidence of asthma over two decades in the European Community Respiratory Health Survey.
    Thorax. 2025 Apr 29:thorax-2024-222307. doi: 10.1136/thorax-2024-222307.
    PubMed     Abstract available


  41. RUPANI H
    Is this the unified asthma guideline we've been waiting for?
    Thorax. 2025 Apr 24:thorax-2025-223056. doi: 10.1136/thorax-2025-223056.
    PubMed    


  42. BERGMANN M, Andersen ZJ, Massling A, Loft S, et al
    Short-term exposure to ultrafine particles and asthma hospital admissions in children in Copenhagen, Denmark.
    Thorax. 2025 Apr 24:thorax-2024-222465. doi: 10.1136/thorax-2024-222465.
    PubMed     Abstract available



  43. BTS/NICE/SIGN joint guideline on asthma: diagnosis, monitoring and chronic asthma management (November 2024) - summary of recommendations.
    Thorax. 2025 Apr 24:thorax-2024-222910. doi: 10.1136/thorax-2024-222910.
    PubMed    


  44. WANG R, Maidstone R, Singh D, Ray D, et al
    The impact of dosage timing for inhaled corticosteroids in asthma: a randomised three-way crossover trial.
    Thorax. 2025 Apr 15:thorax-2024-222073. doi: 10.1136/thorax-2024-222073.
    PubMed     Abstract available


  45. SMALLCOMBE N, Russell RE
    Chronotherapy in asthma: BD or not BD? That is the question.
    Thorax. 2025 Apr 15:thorax-2025-223094. doi: 10.1136/thorax-2025-223094.
    PubMed    


  46. CHO EE, Maclagan LC, Chu A, Croxford R, et al
    Impact of COPD on cardiovascular risk factors and outcomes in people with established cardiovascular disease.
    Thorax. 2025;80:291-299.
    PubMed     Abstract available


  47. MARCALO R, Rodrigues G, Pinheiro M, Neto S, et al
    Functional impairment in COPD can be predicted using genomic-derived data.
    Thorax. 2025;80:283-290.
    PubMed     Abstract available


  48. WHITTAKER H, Kramer Fiala Machado A, Hatam S, Cook S, et al
    Incidence and prevalence of asthma, chronic obstructive pulmonary disease and interstitial lung disease between 2004 and 2023: harmonised analyses of longitudinal cohorts across England, Wales, South-East Scotland and Northern Ireland.
    Thorax. 2025 Apr 8:thorax-2024-222699. doi: 10.1136/thorax-2024-222699.
    PubMed     Abstract available


    March 2025
  49. RAGUNAYAKAM N, Thakar A, Sadafi H, Venegas Garrido C, et al
    Computational fluid dynamics model predictions of inhaled corticosteroid deposition in patients with severe asthma.
    Thorax. 2025 Mar 27:thorax-2024-222444. doi: 10.1136/thorax-2024-222444.
    PubMed     Abstract available


  50. POLLOCK J, Polverino E, Dhar R, Dimakou K, et al
    Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
    Thorax. 2025 Mar 23:thorax-2024-221825. doi: 10.1136/thorax-2024-221825.
    PubMed     Abstract available


  51. MUBANGA M, Gong T, Smew AI, Wikstrom A, et al
    Association between asthma and type 2 diabetes in a Swedish adult population: a register-based cross-sectional study.
    Thorax. 2025 Mar 23:thorax-2024-222819. doi: 10.1136/thorax-2024-222819.
    PubMed     Abstract available


  52. STORGAARD PETERSEN R, Hallas H, Brustad N, Chawes B, et al
    Short-term efficacy of inhaled short-acting beta-2-agonists for acute wheeze/asthma symptoms in preschool-aged children: a systematic review and meta-analysis.
    Thorax. 2025 Mar 23:thorax-2024-222760. doi: 10.1136/thorax-2024-222760.
    PubMed     Abstract available


  53. THOMPSON C, Middleton PG
    Inhaled corticosteroids may be useful in bronchiectasis with peripheral blood eosinophilia.
    Thorax. 2025 Mar 23:thorax-2025-223053. doi: 10.1136/thorax-2025-223053.
    PubMed    


  54. RAVELING T, Boersma R, Wijkstra PJ, Duiverman ML, et al
    Clinical benefit of chronic non-invasive ventilation in severe stable COPD: a matter of persistent hypercapnia improvement.
    Thorax. 2025;80:202-208.
    PubMed     Abstract available


  55. GLOECKL R, Spielmanns M, Stankeviciene A, Plidschun A, et al
    Smartphone application-based pulmonary rehabilitation in COPD: a multicentre randomised controlled trial.
    Thorax. 2025;80:209-217.
    PubMed     Abstract available


  56. MACHADO A, Dias C, Paixao C, Goncalves AP, et al
    Short-term effects of home-based pulmonary rehabilitation during outpatient-managed exacerbations of COPD: a randomised controlled trial.
    Thorax. 2025;80:218-226.
    PubMed     Abstract available


  57. BAILEY G, Ridge CA
    Pulmonary microvascular blood volume and emphysema: in vivo link shown in the MESA cohort.
    Thorax. 2025 Mar 13:thorax-2025-223133. doi: 10.1136/thorax-2025-223133.
    PubMed    


  58. BAE E, Park HJ, Park H, Lee JK, et al
    Early clinical remission and its role in lung function decline and exacerbation in adult Korean patients with asthma.
    Thorax. 2025 Mar 6:thorax-2024-222679. doi: 10.1136/thorax-2024-222679.
    PubMed     Abstract available


    February 2025
  59. KIVISTO JE, Protudjer JLP, Ekstrom S, Karjalainen J, et al
    Adult asthma hospitalisations decreased markedly in Finland and Sweden between 2006 and 2022.
    Thorax. 2025 Feb 8:thorax-2024-222417. doi: 10.1136/thorax-2024-222417.
    PubMed     Abstract available


    January 2025
  60. IOANNIDES AE, Kallis C, Whittaker HR, Quint JK, et al
    Inhaled corticosteroids and major cardiovascular events in people with chronic obstructive pulmonary disease.
    Thorax. 2025;80:67-75.
    PubMed     Abstract available


  61. VAN DER VEER T, Andrinopoulou ER, Braunstahl GJ, Charbonnier JP, et al
    Association between automatic AI-based quantification of airway-occlusive mucus plugs and all-cause mortality in patients with COPD.
    Thorax. 2025;80:105-108.
    PubMed     Abstract available


  62. DOUMAT G, El Zein J, Mehta GD, Zhu Z, et al
    Association between vitamin D status at 3 years and eosinophilic asthma in 6-year-old children with a history of severe bronchiolitis.
    Thorax. 2025 Jan 6:thorax-2024-222099. doi: 10.1136/thorax-2024-222099.
    PubMed     Abstract available


    December 2024
  63. HERRON M, Roche S, Fraughen DD, Heeney RC, et al
    Optimising bronchoalveolar lavage: lessons from alpha-1 antitrypsin deficiency.
    Thorax. 2024;80:24-31.
    PubMed     Abstract available


  64. LAVOIE G, Howell I, Melhorn J, Borg C, et al
    Effects of azithromycin in severe eosinophilic asthma with concomitant monoclonal antibody treatment.
    Thorax. 2024 Dec 18:thorax-2024-221977. doi: 10.1136/thorax-2024-221977.
    PubMed     Abstract available


  65. GRAUL EL, Janson C
    Cost-related nonadherence to medication among people with asthma in the United States: findings that reinforce the relevance of history and healthcare reform.
    Thorax. 2024 Dec 9:thorax-2024-222662. doi: 10.1136/thorax-2024-222662.
    PubMed    


  66. HUNG CT, Erickson SR, Wu CH
    Cost-related non-adherence to medications among adults with asthma in the USA, 2011-2022.
    Thorax. 2024 Dec 9:thorax-2024-221778. doi: 10.1136/thorax-2024-221778.
    PubMed     Abstract available


    November 2024
  67. PALJARVI T, Forton JT, Thompson C, Luciano S, et al
    Neuropsychiatric diagnoses after montelukast initiation in paediatric patients with asthma.
    Thorax. 2024 Nov 22:thorax-2024-221590. doi: 10.1136/thorax-2024-221590.
    PubMed     Abstract available


  68. EVANGELOPOULOS D, Zhang H, Chatzidiakou L, Walton H, et al
    Air pollution and respiratory health in patients with COPD: should we focus on indoor or outdoor sources?
    Thorax. 2024;79:1116-1123.
    PubMed     Abstract available


  69. HERMANN EA, Motahari A, Hoffman EA, Sun Y, et al
    Associations of pulmonary microvascular blood volume with per cent emphysema and CT emphysema subtypes in the community: the MESA Lung study.
    Thorax. 2024 Nov 4:thorax-2024-222002. doi: 10.1136/thorax-2024-222002.
    PubMed     Abstract available


    October 2024
  70. YEN FS, Hsu CC, Wei JC, Tsai FJ, et al
    Glucagon-like peptide-1 receptor agonists may benefit cardiopulmonary outcomes in patients with COPD.
    Thorax. 2024;79:1017-1023.
    PubMed     Abstract available


  71. PHILIP J, Chang YK, Collins A, Smallwood N, et al
    Consensus palliative care referral criteria for people with chronic obstructive pulmonary disease.
    Thorax. 2024;79:1006-1016.
    PubMed     Abstract available


  72. LO D, Lawson C, Gillies C, Shabnam S, et al
    Association between socioeconomic deprivation, ethnicity and health outcomes in preschool children with recurrent wheeze in England: a retrospective cohort study.
    Thorax. 2024;79:1050-1059.
    PubMed     Abstract available


    September 2024
  73. FILIPOW N, Turner S, Petsky HL, Chang AB, et al
    Variability in forced expiratory volume in 1 s in children with symptomatically well-controlled asthma.
    Thorax. 2024 Sep 27:thorax-2024-221755. doi: 10.1136/thorax-2024-221755.
    PubMed     Abstract available


  74. BRUSTAD N, Thorsen J, Pedersen CET, Ali M, et al
    Urban metabolic and airway immune profiles increase the risk of infections in early childhood.
    Thorax. 2024;79:943-952.
    PubMed     Abstract available


    August 2024
  75. NORDLUND B
    Inequalities in care and the burden of wheeze and asthma in young children from diverse socioeconomic and ethnic backgrounds.
    Thorax. 2024 Aug 17:thorax-2024-222111. doi: 10.1136/thorax-2024-222111.
    PubMed    


    July 2024
  76. TATON O, Gevenois PA, Van Muylem A, Bondue B, et al
    Improvements of the shape and strength of the diaphragm after endoscopic lung volume reduction.
    Thorax. 2024;79:711-717.
    PubMed     Abstract available


  77. LICSKAI C, Hussey A, Rowley V, Ferrone M, et al
    Quantifying sustained health system benefits of primary care-based integrated disease management for COPD: a 6-year interrupted time series study.
    Thorax. 2024;79:725-734.
    PubMed     Abstract available


  78. GERSHON AS, Blazer A, Ko D
    Undertreating cardiovascular disease in people with chronic obstructive pulmonary disease (COPD).
    Thorax. 2024;79:705-706.
    PubMed    


  79. GRANELL R, Haider S, Deliu M, Ullah A, et al
    Lung function trajectories from school age to adulthood and their relationship with markers of cardiovascular disease risk.
    Thorax. 2024;79:770-777.
    PubMed     Abstract available


  80. AMEGADZIE JE, Gao Z, Quint JK, Russell R, et al
    QRISK3 underestimates the risk of cardiovascular events in patients with COPD.
    Thorax. 2024;79:718-724.
    PubMed     Abstract available


  81. KARP T, Faiz A, van Nijnatten J, Kerstjens HAM, et al
    Nasal epithelial gene expression identifies relevant asthma endotypes in the ATLANTIS study.
    Thorax. 2024 Jul 15:thorax-2023-221230. doi: 10.1136/thorax-2023-221230.
    PubMed     Abstract available


    May 2024
  82. GHOSH M, Vladar EK
    Extensive airway remodelling in severe COPD imparts resiliency to environmental stressors.
    Thorax. 2024;79:491-492.
    PubMed    


  83. KOEFOED HJL, Wang G, Gehring U, Ekstrom S, et al
    Clinical implications of airway obstruction with normal or low FEV(1) in childhood and adolescence.
    Thorax. 2024;79:573-580.
    PubMed     Abstract available


  84. LIANG C, Chung HF, Dobson A, Sandin S, et al
    Female reproductive histories and the risk of chronic obstructive pulmonary disease.
    Thorax. 2024;79:508-514.
    PubMed     Abstract available


  85. STOLERIU MG, Ansari M, Strunz M, Schamberger A, et al
    COPD basal cells are primed towards secretory to multiciliated cell imbalance driving increased resilience to environmental stressors.
    Thorax. 2024;79:524-537.
    PubMed     Abstract available


    April 2024
  86. JENKINS AR, Burtin C, Camp PG, Lindenauer P, et al
    Do pulmonary rehabilitation programmes improve outcomes in patients with COPD posthospital discharge for exacerbation: a systematic review and meta-analysis.
    Thorax. 2024;79:438-447.
    PubMed     Abstract available


  87. WU T, Santos S, Quezada-Pinedo HG, Vernooij MW, et al
    Body composition and respiratory outcomes in children: a population-based prospective cohort study.
    Thorax. 2024;79:448-456.
    PubMed     Abstract available


  88. GRUDZINSKA FS, Scott A
    Unravelling the neutrophil enigma: a new insight into RSV-induced bronchiolitis in infants.
    Thorax. 2024 Apr 4:thorax-2023-221130. doi: 10.1136/thorax-2023-221130.
    PubMed    


    March 2024
  89. PETOUSI N, Pavord ID, Kent BD
    Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease.
    Thorax. 2024;79:291-292.
    PubMed    


  90. CELIS-PRECIADO CA, Lachapelle P, Couillard S
    Blood eosinophils take centre stage in predicting the response to sublingual immunotherapy (SLIT): a familiar twist.
    Thorax. 2024;79:297-298.
    PubMed    


  91. VOGIATZIS I
    Role of blood flow restriction strength training in chronic obstructive pulmonary disease.
    Thorax. 2024;79:289-290.
    PubMed    


  92. COLAK Y, Afzal S, Marott JL, Vestbo J, et al
    Type-2 inflammation and lung function decline in chronic airway disease in the general population.
    Thorax. 2024;79:349-358.
    PubMed     Abstract available


  93. KOHLBRENNER D, Kuhn M, Manettas A, Aregger C, et al
    Low-load blood flow restriction strength training in patients with COPD: a randomised single-blind pilot study.
    Thorax. 2024;79:340-348.
    PubMed     Abstract available


  94. WANG KCW, Blakey JD
    Impacts of sex and gender on severe asthma.
    Thorax. 2024 Mar 7:thorax-2023-221117. doi: 10.1136/thorax-2023-221117.
    PubMed    


  95. MORGAN AD
    Unravelling the obesity-asthma connection in childhood and adolescence: does body shape matter?
    Thorax. 2024 Mar 7:thorax-2023-221345. doi: 10.1136/thorax-2023-221345.
    PubMed    


    February 2024
  96. WILKINSON AJK, Maslova E, Janson C, Radhakrishnan V, et al
    Greenhouse gas emissions associated with suboptimal asthma care in the UK: the SABINA healthCARe-Based envirONmental cost of treatment (CARBON) study.
    Thorax. 2024 Feb 27:thorax-2023-220259. doi: 10.1136/thorax-2023-220259.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum